Aqemia’s differentiated discovery platform creates ‘bright future ahead’

In an industry where many companies claim to be reinventing the wheel, it is rare to find one that is truly doing something different—and winning recognition from big pharma for doing so.

But perhaps Aqemia, a drug invention company combining generative AI and quantum-inspired physics, fits the bill, by bringing an entirely new perspective to drug discovery that is not rooted to the flawed methodology of the past.

This differentiation is best explained by understanding how the French company came about.